Niraj Rajnikant Shah has bought 9,25,000 shares, acquiring a 6.44% stake in Bacil Pharma through open market transactions between June 22-24, 2026. This increases individual investor influence.

Niraj Shah Buys 6.44% Stake in Bacil Pharma

Niraj Rajnikant Shah has acquired 9,25,000 equity shares, representing a 6.44% stake, in Bacil Pharma Ltd. The transactions occurred in the open market between June 22 and June 24, 2026.

What just happened

Individual investor Niraj Rajnikant Shah bought 9,25,000 shares of Bacil Pharma.

Why this matters

This significant open market purchase by one individual investor increases their holding to 6.44% of the company's equity.

The backstory

Bacil Pharma's total equity share capital stands at 1,43,53,000 shares.

What changes now

The shareholder base has changed with a substantial accumulation by a single investor over three days.

Risks to watch

Investors should monitor for future filings from the acquirer regarding their intentions.

Peer comparison

No direct peer comparison is available from the filing.

Context metrics (time-bound)

• Shares Acquired: 9,25,000
• Stake Acquired: 6.44%
• Transaction Period: June 22, 2026 – June 24, 2026

What to track next

Follow future SEBI disclosures from Niraj Rajnikant Shah for any changes in shareholding.